EN DE
STOCK COMPARISON

Guangxi Wuzhou Zhongheng Group Co vs Merck & Company: Fair Value & Quality

Both stocks run through our valuation models. Here is how Guangxi Wuzhou Zhongheng Group Co (600252) and Merck & Company (MRK) compare, as of Aug 25, 2026.

As of Aug 25, 2026, Fair Value Calculator sees Merck & Company as the less overvalued of the two: Guangxi Wuzhou Zhongheng Group Co trades at ¥2.18 versus a fair value of ¥0.33 (-85%), while Merck & Company trades at $151 versus $125 (-17%).
Guangxi Wuzhou Zhongheng Group Co
600252.SHG · CNY · Health Care
-85%
upside to fair value
overvalued
Price¥2.18
Fair Value¥0.33
Quality47/100
Merck & Company
MRK · USD · Health Care
-17%
upside to fair value
overvalued
Price$151
Fair Value$125
Quality70/100
Get comparisons like this free by email every month: the most undervalued quality stocks.

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

Guangxi Wuzhou Zhongheng Group CoMerck & Company
Valuation
—P/E (TTM)43.6×
0.66×P/S (TTM)4.64×
0.19×P/B5.80×
—EV/EBITDA11.4×
—PEG6.10×
0.8%Dividend yield2.2%
—Dividend per share$3.28
Profitability
-26%Net margin14%
-4%Operating margin39%
-8%Return on equity19%
-2%Return on assets13%
Growth
-32%Revenue growth (YoY)5%
-13.6%Avg. growth/yr (3Y)3.1%
-13.8%Avg. growth/yr (5Y)9.4%
Balance & size
0.09×Debt / equity0.89×
$1BMarket cap$305B
weakGrowth qualityhealthy

Merck & Company leads: 3 to 8 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Guangxi Wuzhou Zhongheng Group Coof which business quality 46 · market factors 40 Merck & Companyof which business quality 68 · market factors 87
ProfitabilityMargins and returns on capital today
5
74
Quality GrowthAre margins and returns improving?
32
36
CashflowEarnings quality: real cash, not paper profit
4
65
Fin. StrengthBalance sheet, leverage, solvency risk
77
68
InvestmentDisciplined investing over empire-building
93
71
Low VolatilityCalm price path (market factor)
80
84
MomentumPrice trend over the last 3–12 months (market factor)
24
82
52W MomentumDistance to the 52-week high (market factor)
21
100
Net IssuanceBuybacks instead of dilution
100
91

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

Guangxi Wuzhou Zhongheng Group Co

Dividend Discount¥0.27
Asset-Based¥1.13

3 of 3 models see the stock below the current price.

Merck & Company

DCF Models$117
Earnings-Based$62.77
Dividend Discount$60.35
Multiples$122
Asset-Based$14.27
Growth DCF$74.00
Economic Profit$83.85
Growth Earnings$138

24 of 26 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Guangxi Wuzhou Zhongheng Group Co
Bear ¥0.16Fair Value ¥0.33Bull ¥0.51
¥2.18 = current price (white tick)
Merck & Company
Bear $70.92Fair Value $125Bull $188
$151 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Guangxi Wuzhou Zhongheng Group Co · Health Care

Quality score47 · below median
Fair value upside-85% · bottom 25%

Merck & Company · Health Care

Quality score70 · Top 25%
Fair value upside-17% · above median

Bottom line

As of Aug 25, 2026, Fair Value Calculator sees Merck & Company as the less overvalued of the two: Guangxi Wuzhou Zhongheng Group Co trades at ¥2.18 versus a fair value of ¥0.33 (-85%), while Merck & Company trades at $151 versus $125 (-17%).

Merck & Company has the higher quality score (70/100).

See the full analysis →
Guangxi Wuzhou Zhongheng Group Co · Merck & Company

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Related to Guangxi Wuzhou Zhongheng Group Co

Eli Lilly and vs UnitedHealth GroupJohnson & Johnson vs UnitedHealth GroupAbbVie vs UnitedHealth GroupUnitedHealth Group vs Merck & Company

Related to Merck & Company

UnitedHealth Group vs AstraZenecaUnitedHealth Group vs Thermo Fisher ScientificUnitedHealth Group vs AmgenUnitedHealth Group vs Abbott Laboratories
Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 26 models. Values change with price and fundamentals; the date shown above applies.